CVS Health may be forced to close over 20 Arkansas stores following PBM law
CVS Health had lobbied against the law, running TV ads and calling on the governor to veto the bill. The company says the law will harm patients and the economy.
CVS Health had lobbied against the law, running TV ads and calling on the governor to veto the bill. The company says the law will harm patients and the economy.
Dowsett will lead NACDS’ strategic communications, media relations, social media, website, and design functions.
Pharmacy groups applaud Trump's drug pricing executive order.
Arkansas HB 1150 a model for other states, federal government, organizations say.
AutoPack, supports up to 480 medications in a single packager.
NACDS emphasizes the importance of enacting the sound reforms that are ready to go and broadly supported in Congress.
“This partnership of like-minded, national organizations is an effective way to harness support and mobilize resources,” said Eric Mitchell, President of the Alliance to End Hunger.
Executive order calls for lowering the costs of life-saving drugs for low-income patients.
By Dr. Monica Trivedi at Marshall B. Ketchum University
The agreement results from 18 months of collaboration between Inmar and DEA officials to interpret regulations on reverse distribution of controlled substances.
SB 252 was crafted to bring long-overdue transparency to prescription drug pricing, ensure fair reimbursement for pharmacies, and rein in abusive PBM practices that have contributed to rising drug costs and the closure of community pharmacies across the state.
“AAM and the generics and biosimilars industry look forward to working with the Commerce Department and the White House to engage constructively on ways to incent more domestic investment in the medicines supply chain,” said John Murphy III, president and CEO.
Scholarships will help reduce financial barriers for student pharmacists.
Saves more than $800 million over 10 years; brings lower-cost medicines to patients soone
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
It’s uncertain whether tariffs will influence more companies to make more drugs in the U.S. like Trump is hoping for, some experts said.